ICVX Company Profile and Key Details
Icosavax, Inc.
ICVX Stock Price Chart
Stock Price Today
Icosavax, Inc. (ICVX) stock declined over -0.91%, trading at $15.31 on NASDAQ, down from the previous close of $15.45. The stock opened at $15.40, fluctuating between $15.28 and $15.44 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Icosavax, Inc., a biopharmaceutical company, develops vaccines against infectious diseases. The company, with the help of its virus-like particle (VLP) platform technology, focuses primarily on life-threatening respiratory diseases. Its products in pipeline include IVX-121, a vaccine candidate with RSV target and is under Phase 1/1b clinical trial; IVX-A12, a respiratory syncytial virus (RSV) monovalent antigen candidate with RSV/human metapneumovirus (hMPV) bivalent target indication; IVX-241, a vaccine candidate with hMPV target; and IVX-411, an original receptor binding domain (RBD) sequence antigen with SARS-CoV-2 target indication and is under Phase 1/2 clinical trial. The company was incorporated in 2017 and is headquartered in Seattle, Washington.
Company Information
| Employees | 60 |
| Beta | 1.28 |
| Sales or Revenue | $0.00 |
| 5Y Sales Change% | 0% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
Icosavax, Inc. (NASDAQ: ICVX) stock price is $15.31 in the last trading session. During the trading session, ICVX stock reached the peak price of $15.44 while $15.28 was the lowest point it dropped to. The percentage change in ICVX stock occurred in the recent session was -0.91% while the dollar amount for the price change in ICVX stock was -$0.14.
The NASDAQ listed ICVX is part of Biotechnology industry that operates in the broader Healthcare sector. Icosavax, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Mr. Neil King Ph.D.
Chair of Scientific Advisory Board & Co-Founder
Dr. Cassia Cearley Ph.D.
Treasurer & Chief Bus. Officer
Mr. Adam K. Simpson
Pres, Chief Executive Officer, Co-Founder & Director
Ms. Lori Stewart
Senior Vice President of People & Culture
Ms. Elizabeth Bekiroglu
Gen. Counsel & Corporation Sec.
Dr. Ami Shah Brown MPH, Ph.D.
Senior Vice President of Regulatory Affairs
Dr. Charles E. Richardson Ph.D.
Senior Vice President of Technical Operations
Mr. Niranjan Kanesa-thasan M.D.
Chief Medical Officer
Ms. Jennifer Raymond
Senior Vice President of Technical Operations
Mr. Thomas Joseph Russo C.F.A.
Chief Financial Officer
Mr. Douglas A. Holtzman M.P.H., Ph.D.
Chief Scientific Officer
ICVX's closing price is 222.32% higher than its 52-week low of $4.75 where as its distance from 52-week high of $16.11 is -4.94%.
Number of ICVX employees currently stands at 60.
Official Website of ICVX is: https://icosavax.com
ICVX could be contacted at phone 206 737 0085 and can also be accessed through its website. ICVX operates from 1616 Eastlake Avenue East, Seattle, WA 98102, United States.
ICVX stock volume for the day was 8.56M shares. The average number of ICVX shares traded daily for last 3 months was 1.05M.
The market value of ICVX currently stands at $769.04M with its latest stock price at $15.31 and 50.23M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com